in six of the seven subjects. The range of magnitude of the rise in FT3 was 30-70% above the baseline value (mean 48%) for these six subjects. The expected rise in FT4 also occurred in all seven subjects and was of greater magnitude (range 87-400%: mean = 173%).These results confirm that heparin induces a sustained rise in FT3 as well as FT4, but do not confirm that this phenomenon is associated with any metabolic effect, in the form of suppression of TSH levels. They do not, however, exclude the possibility that other metabolic effects may occur. Indeed we would suggest that since heparin also produces elevated free fatty acid levels, which may be associated with the development of cardiac arrythmias (Kurien, Yates & Oliver, 1969; Kurien & Oliver, 1970), there is a need for further investigation into the possibility that the elevated free thyroid hormone levels, produced by this drug, may have direct tissue effects.